A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition (NIH).
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker
Check out UGenome’s ProPEx™ to see how you can generate revenue from your Next Generation Sequencing data. UGenome’s ProPEx™ is the most comprehensive a PGx report on the market. The report generated examines a total of 86 genes and can be added to your offering report list to your customers.
Learn More
Genomic Software Products –> MAXX™, ProPEx™, and in 2025 Seq4Life™
Pharmacogenomic Case Studies –> Depression, Pain Control, Folic Acid, Tacrolimus in Kidney transplant patient
Bioinformatics Services –> Genomics, Transcriptomics, Proteomics, Metabolomics
Bioinformatics Case Studies –> Extrachromosomal DNA detection & Metabolite Identification
See UGenome in the News and read our leading Emerging Trends series in which we cover topics ranging from Adverse Drug Reactions, Mental Health & PGx, Renal + Transplantation & PGx, NGS for PGx Testing, Rare Disease with our partner Jura.Health, Cancer & PGx, and the Integration of PGx with Clinical Practice.
The UGenome Team combines successful SaaS, commercialization, computational biology, clinical pharmacy, and engineering to create world-class PGx tools. Zachary S. Brooks Jayden Lee, EMBA, PharmD, BCACP, Peter Bannister, MEng (Oxon) DPhil MBA CEng FIET, Komal Sharma, M.S., MBA, Ben Stansfield, PhD – Genetics, Anishek Kamal, MBA (Data & AI Architect)